Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
20 studies found for:    Open Studies | "Carcinoma, Small Cell"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Not yet recruiting Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma
Condition: Small Cell Carcinoma
Interventions: Drug: Nortriptyline Hydrochloride;   Drug: Paclitaxel
2 Recruiting Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Conditions: Non-Small Cell Lung Cancer;   Small Cell Lung Cancer;   Extrapulmonary Small Cell Cancer;   Pulmonary Neuroendocrine Tumors;   Thymic Epithelial Tumors
Intervention:
3 Not yet recruiting Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
Conditions: Carcinoma, Small Cell;   Lung Neoplasms
Interventions: Radiation: hypofractionated concurrent chemoradiotherapy;   Radiation: conventionally fractionated concurrent chemoradiotherapy
4 Not yet recruiting Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer
Conditions: Carcinoma, Small Cell;   Lung Neoplasms
Interventions: Radiation: high-dose TRT;   Radiation: standard-dose TRT
5 Recruiting TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)
Condition: Carcinoma, Small Cell
Intervention: Drug: ARQ197
6 Recruiting Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study
Condition: Carcinoma, Small Cell
Intervention: Radiation: Whole brain radiotherapy with reduced dose to the hippocampi
7 Unknown † Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient
Condition: Carcinoma, Small Cell
Interventions: Drug: Belotecan/Cisplatin;   Drug: Etoposide/Cisplatin
8 Recruiting HS-WBRT for Prophylactic Cranial Irradiation in Limited Stage Small Cell Lung Cancer
Condition: Carcinoma, Small Cell Lung
Interventions: Radiation: HS-WBRT PCI;   Radiation: Conventional PCI
9 Recruiting Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Carcinoma, Thymic
Interventions: Drug: AZD6244;   Drug: MK-2206;   Drug: Lapatinib;   Drug: Erlotinib;   Drug: Sunitinib;   Procedure: Molecular Profiling
10 Unknown † N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Mesothelioma
Interventions: Drug: N-Acetylcysteine;   Drug: Placebo
11 Recruiting Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung
Intervention: Other: 13-C-glucose
12 Unknown † Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
Condition: Small Cell Carcinoma of Lung
Intervention: Drug: Irinotecan
13 Recruiting Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Condition: Bladder Cancer
Interventions: Radiation: Prophylactic Cranial Irradiation (PCI);   Other: Brain X-ray
14 Recruiting Circulating Tumor DNA in Patients at High Risk for Lung Cancer
Conditions: Cancer of the Lung;   Lung Cancer;   Lung Neoplasms;   Adenocarcinoma of the Lung;   Non Small Cell Carcinoma of the Lung;   Small Cell Carcinoma of the Lung
Intervention:
15 Recruiting International Ovarian & Testicular Stromal Tumor Registry
Conditions: Ovarian Stromal Tumor;   Testicular Stromal Tumors;   Ovarian Small Cell Carcinoma
Intervention:
16 Not yet recruiting Olaparib With or Without Cediranib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation;   Prostate Carcinoma Metastatic in the Bone;   Prostate Small Cell Carcinoma;   Stage IV Prostate Adenocarcinoma
Interventions: Drug: Cediranib;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib
17 Unknown † Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Gemcitabine and Docetaxel
18 Recruiting Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix
Condition: Cervical Cancer
Intervention: Behavioral: Questionnaires
19 Unknown † Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: panitumumab;   Drug: cisplatin;   Radiation: brachytherapy;   Radiation: external beam radiation therapy
20 Unknown † Collecting Tumor Samples From Patients With Gynecological Tumors
Condition: Cancer
Intervention: Other: biologic sample preservation procedure
To Top

† Indicates status has not been verified in more than two years